Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT[sub 2] receptors.

Saved in:
Bibliographic Details
Title: Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT[sub 2] receptors.
Authors: Sargent, P. A., Quested, D. J., Cowen, P. J.
Source: Psychopharmacology. 1998, Vol. 140 Issue 1, p120. 3p.
Subjects: Hydroxytryptophan, Antidepressants, Serotonin uptake inhibitors, Hydrocortisone
Abstract: Abstract We measured the cortisol response to the 5-HT precursor, 5-hydroxytryptophan, (5-HTP) in seven patients with major depression before and after 8 weeks treatment with the tricyclic antidepressant, clomipramine. The cortisol response to 5-HTP was significantly increased following clomipramine treatment, suggesting that clomipramine, like selective serotonin re-uptake inhibitors (SSRIs), enhances this 5-HT[sub 2] receptor mediated response. Because other tricyclic antidepressants do not increase 5-HTP-mediated cortisol release, it seems unlikely that enhancement of 5-HT[sub 2] receptor function is a critical mechanism for antidepressant action. However, facilitation of neurotransmission at 5-HT[sub 2] receptors could account for the efficacy of clomipramine and SSRIs in the treatment of obsessive compulsive disorder and also for their liability to cause orgasmic dysfunction. [ABSTRACT FROM AUTHOR]
Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Abstract We measured the cortisol response to the 5-HT precursor, 5-hydroxytryptophan, (5-HTP) in seven patients with major depression before and after 8 weeks treatment with the tricyclic antidepressant, clomipramine. The cortisol response to 5-HTP was significantly increased following clomipramine treatment, suggesting that clomipramine, like selective serotonin re-uptake inhibitors (SSRIs), enhances this 5-HT[sub 2] receptor mediated response. Because other tricyclic antidepressants do not increase 5-HTP-mediated cortisol release, it seems unlikely that enhancement of 5-HT[sub 2] receptor function is a critical mechanism for antidepressant action. However, facilitation of neurotransmission at 5-HT[sub 2] receptors could account for the efficacy of clomipramine and SSRIs in the treatment of obsessive compulsive disorder and also for their liability to cause orgasmic dysfunction. [ABSTRACT FROM AUTHOR]
ISSN:00333158
DOI:10.1007/s002130050747